PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
To evaluate the use of Purabond® in transoral resections of primary oral or oropharyngeal lesions for diagnostic and therapeutic procedures. Patients will be enrolled and randomised to either have PuraBond® applied to the surgical field or not intra operatively. The primary outcome measure will assess if this intervention significantly reduces acute pain during the 30 day post-operative period alongside other post-operative complication rates and recovery outcomes.
Epistemonikos ID: 69f66c7caa7d4223ac70fe40248b82bfc2acf124
First added on: Feb 19, 2024